Total Payments
$3,423
2024 Payments
$521.26
Companies
18
Transactions
144
Payment Breakdown by Category
Food & Beverage$3,393 (99.1%)
Education$29.99 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,393 | 143 | 99.1% |
| Education | $29.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $640.97 | 42 | $0 (2019) |
| Allergan, Inc. | $628.52 | 17 | $0 (2020) |
| Neos Therapeutics, LP | $520.47 | 29 | $0 (2019) |
| PFIZER INC. | $259.72 | 14 | $0 (2018) |
| Tris Pharma Inc | $251.91 | 5 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $232.40 | 10 | $0 (2020) |
| Axsome Therapeutics, Inc. | $223.17 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $143.90 | 7 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $129.02 | 1 | $0 (2024) |
| Neuronetics, Inc. | $112.96 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $521.26 | 4 | Tris Pharma Inc ($171.92) |
| 2023 | $98.92 | 1 | Axsome Therapeutics, Inc. ($98.92) |
| 2022 | $34.74 | 2 | Supernus Pharmaceuticals, Inc. ($34.74) |
| 2021 | $18.10 | 1 | Bausch Health US, LLC ($18.10) |
| 2020 | $87.47 | 4 | Ironshore Pharmaceuticals Inc. ($36.73) |
| 2019 | $1,210 | 48 | Allergan Inc. ($534.74) |
| 2018 | $593.84 | 34 | Shire North American Group Inc ($235.36) |
| 2017 | $858.93 | 50 | Neos Therapeutics, LP ($332.08) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 4 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2018 | PFIZER INC. | QUILLIVANT XR (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ADHD | ||||||
| 05/16/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: ADHD | ||||||
| 05/15/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: ADHD | ||||||
| 05/04/2018 | PFIZER INC. | QUILLIVANT XR (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2018 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: ADHD | ||||||
| 04/04/2018 | PFIZER INC. | QUILLIVANT XR (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2018 | PFIZER INC. | QUILLICHEW ER (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: ADHD | ||||||
| 02/07/2018 | PFIZER INC. | QUILLICHEW ER (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2018 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2018 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: ADHD | ||||||
| 12/12/2017 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ADHD | ||||||
| 12/11/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2017 | PFIZER INC. | QUILLIVANT XR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2017 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ADHD | ||||||
| 11/16/2017 | PFIZER INC. | QUILLIVANT XR (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Sharlaw Bhargava, M.D
Dr. Sharlaw Bhargava, M.D is a Child & Adolescent Psychiatry healthcare provider based in Prosper, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720151368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharlaw Bhargava, M.D has received a total of $3,423 in payments from pharmaceutical and medical device companies, with $521.26 received in 2024. These payments were reported across 144 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,393).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Prosper, TX
- Active Since 11/15/2006
- Last Updated 07/17/2007
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1720151368
Products in Payments
- VRAYLAR (Drug) $591.60
- Adzenys XR-ODT (Drug) $447.98
- VYVANSE (Drug) $387.59
- MYDAYIS (Drug) $272.90
- Dyanavel XR (Drug) $226.92
- Auvelity (Drug) $223.17
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $195.67
- QUILLIVANT XR (Drug) $184.19
- SPRAVATO (Drug) $143.90
- UZEDY (Drug) $129.02
- NEUROSTAR TMS THERAPY (Device) $97.55
- QUILLICHEW ER (Drug) $75.53
- Cotempla XR-ODT (Drug) $72.49
- VIIBRYD (Drug) $36.92
- JORNAY PM (Drug) $36.73
- QELBREE (Drug) $34.74
- METHYLPHENIDATE 72 (Drug) $33.53
- ADHANSIA XR (Drug) $33.37
- NUEDEXTA (Drug) $28.36
- Quillivant XR (Drug) $24.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.